Cardiovascular disease is a well-recognized cause of increased late morbidity and mortality among survivors of childhood cancer treated with anthracyclines. Co-administration of Dexrazoxane has been shown to significantly reduce short-term and mid-term cardiotoxicity. Aim of this study was to assess cardiac function in long-term (>10 years) survivors of childhood tumors treated with dexrazoxane/anthracycline association.

Echocardiographic long-term follow-up of adult survivors of pediatric cancer treated with dexrazoxane-anthracyclines association / Filomena, D.; Versacci, P.; Cimino, S.; Mattiucci, C.; Maestrini, V.; Cantisani, D.; Petronilli, V.; Agati, L.; Schiavetti, A.. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - 2019:Aug 5(2019). [10.1016/j.ijcard.2019.07.096]

Echocardiographic long-term follow-up of adult survivors of pediatric cancer treated with dexrazoxane-anthracyclines association

Filomena D.
;
Versacci P.;Cimino S.;Mattiucci C.;Maestrini V.;Cantisani D.;Petronilli V.;Agati L.;Schiavetti A.
2019

Abstract

Cardiovascular disease is a well-recognized cause of increased late morbidity and mortality among survivors of childhood cancer treated with anthracyclines. Co-administration of Dexrazoxane has been shown to significantly reduce short-term and mid-term cardiotoxicity. Aim of this study was to assess cardiac function in long-term (>10 years) survivors of childhood tumors treated with dexrazoxane/anthracycline association.
2019
anthracycline; cardiotoxicity; dexrazoxane; strain echocardiography
01 Pubblicazione su rivista::01a Articolo in rivista
Echocardiographic long-term follow-up of adult survivors of pediatric cancer treated with dexrazoxane-anthracyclines association / Filomena, D.; Versacci, P.; Cimino, S.; Mattiucci, C.; Maestrini, V.; Cantisani, D.; Petronilli, V.; Agati, L.; Schiavetti, A.. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - 2019:Aug 5(2019). [10.1016/j.ijcard.2019.07.096]
File allegati a questo prodotto
File Dimensione Formato  
Filomena_Echocardiographic_2019.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 267.75 kB
Formato Adobe PDF
267.75 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1306135
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 10
social impact